Literature DB >> 6833837

Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.

R B Buckingham, R K Prince, G P Rodnan.   

Abstract

Fibroblast monolayers were established by explant culture of dermis from seven patients with early, rapidly advancing PSS (scleroderma) and from six normal individuals. Net GAG synthesis was measured as [3H]glucosamine incorporation into the polymer and also as total uronic acid accumulation in the cultures. Cultures from patients with PSS accumulated up to fivefold more GAG than did normal cultures. Evidence suggests that this is a result of increased synthesis rather than decreased degradation. PSS cultures simultaneously accumulated increased amounts of CSP as well as GAG. Data obtained from studies of several monolayers, followed for as many as 10 generations, show that the difference between PSS and normal cultures can be propagated. The total quantity of GAGs was increased in PSS cultures, and there were differences in the distribution of individual GAGs on a percentage basis in PSS and normal cell cultures. GAG, as well as collagen, may be important in the development of connective tissue thickening and induration in scleroderma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833837

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  13 in total

Review 1.  Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis.

Authors:  B Eckes; D Kessler; M Aumailley; T Krieg
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis.

Authors:  G I Mason; J Hamburger; J B Matthews
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

3.  Response of scleroderma fibroblasts to various growth factors.

Authors:  K Takehara; Y Soma; A Igarashi; K Kikuchi; A Moro; Y Ishibashi
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Origin of the enhanced activity of lysosomal beta-galactosidase in serum and skin in progressive systemic sclerosis.

Authors:  K Herrmann; E Schulze; U F Haustein; H J Böhme; V Ziegler
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma.

Authors:  M R Duncan; B Berman
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

6.  Penicillamine in systemic sclerosis: a reappraisal.

Authors:  M A Sattar; R T Guindi; T N Sugathan
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

7.  Smooth muscle differentiation in scleroderma fibroblastic cells.

Authors:  A P Sappino; I Masouyé; J H Saurat; G Gabbiani
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

8.  Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.

Authors:  Yoshihiro Mimura; Hironobu Ihn; Masatoshi Jinnin; Yoshihide Asano; Kenichi Yamane; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

9.  Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; C Beth Singleton; Jennifer R Bethard; Richard M Silver
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-01       Impact factor: 5.464

10.  The effect of reactive oxygen species on the biosynthesis of collagen and glycosaminoglycans in cultured human dermal fibroblasts.

Authors:  H Tanaka; T Okada; H Konishi; T Tsuji
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.